Cidara Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeCidara Therapeutics
Cidara Therapeutics logo

Cidara Therapeutics

0 followers

CDTX

Performance

About Cidara Therapeutics

Cidara Therapeutics is a biotechnology company focused on developing targeted immunotherapies to improve outcomes for patients with serious diseases. The company emphasizes its Cloudbreak platform, which creates drug-Fc conjugates by attaching targeted small molecules and peptides to a human antibody fragment to engage both disease targets and the immune system. Its pipeline includes clusters in immuno-oncology and influenza, reflecting a focus on therapies that combine precision targeting with immune engagement, and the company is headquartered in San Diego, California.

Recent News

Recent Deals

Key Team Members

Allison Lewis, SPHR, CCP

Senior Vice President, People and Culture

Corrina Pavetto

Senior Vice President, Clinical Development

Jeffrey Stein, Ph.D.

President and Chief Executive Officer

Nicole Davarpanah, M.D., J.D.

Chief Medical Officer

Key Facts

HQ Location

San Diego, United States

Founded

2013

Employees

11 - 50

Status

Public

Website

https://cidara.com